TY - JOUR AU - Emens, L. A. AU - Ascierto, P. A. AU - Darcy, P. K. AU - Demaria, S. AU - Eggermont, A. M. M. AU - Redmond, W. L. PY - 2017 DA - 2017// TI - Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape JO - Eur J Cancer VL - 81 UR - https://doi.org/10.1016/j.ejca.2017.01.035 DO - 10.1016/j.ejca.2017.01.035 ID - Emens2017 ER - TY - JOUR AU - Anderson, K. G. AU - Stromnes, I. M. AU - Greenberg, P. D. PY - 2017 DA - 2017// TI - Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.02.008 DO - 10.1016/j.ccell.2017.02.008 ID - Anderson2017 ER - TY - JOUR AU - Pages, F. AU - Mlecnik, B. AU - Marliot, F. AU - Bindea, G. AU - Ou, F. S. AU - Bifulco, C. PY - 2018 DA - 2018// TI - International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30789-X DO - 10.1016/S0140-6736(18)30789-X ID - Pages2018 ER - TY - JOUR AU - Bertucci, F. AU - Finetti, P. AU - Simeone, I. AU - Hendrickx, W. AU - Wang, E. AU - Marincola, F. M. PY - 2018 DA - 2018// TI - The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer JO - Br J Cancer VL - 119 UR - https://doi.org/10.1038/s41416-018-0309-1 DO - 10.1038/s41416-018-0309-1 ID - Bertucci2018 ER - TY - JOUR AU - Hendrickx, W. AU - Simeone, I. AU - Anjum, S. AU - Mokrab, Y. AU - Bertucci, F. AU - Finetti, P. PY - 2017 DA - 2017// TI - Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis JO - Oncoimmunology VL - 6 UR - https://doi.org/10.1080/2162402X.2016.1253654 DO - 10.1080/2162402X.2016.1253654 ID - Hendrickx2017 ER - TY - JOUR AU - Ayers, M. AU - Lunceford, J. AU - Nebozhyn, M. AU - Murphy, E. AU - Loboda, A. AU - Kaufman, D. R. PY - 2017 DA - 2017// TI - IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade JO - J Clin Investig VL - 127 UR - https://doi.org/10.1172/JCI91190 DO - 10.1172/JCI91190 ID - Ayers2017 ER - TY - JOUR AU - Marabelle, A. AU - Tselikas, L. AU - Baere, T. AU - Houot, R. PY - 2017 DA - 2017// TI - Intratumoral immunotherapy: using the tumor as the remedy JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx683 DO - 10.1093/annonc/mdx683 ID - Marabelle2017 ER - TY - JOUR AU - Dyer, A. AU - Baugh, R. AU - Chia, S. L. AU - Frost, S. AU - Iris AU - Jacobus, E. J. PY - 2018 DA - 2018// TI - Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference JO - Cancer Gene Ther VL - 26 UR - https://doi.org/10.1038/s41417-018-0042-1 DO - 10.1038/s41417-018-0042-1 ID - Dyer2018 ER - TY - JOUR AU - Haanen, J. PY - 2017 DA - 2017// TI - Converting cold into hot tumors by combining immunotherapies JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.08.031 DO - 10.1016/j.cell.2017.08.031 ID - Haanen2017 ER - TY - JOUR AU - Munck, J. AU - Binks, A. AU - McNeish, I. A. AU - Aerts, J. L. PY - 2017 DA - 2017// TI - Oncolytic virus-induced cell death and immunity: a match made in heaven? JO - J Leukoc Biol VL - 102 UR - https://doi.org/10.1189/jlb.5RU0117-040R DO - 10.1189/jlb.5RU0117-040R ID - Munck2017 ER - TY - JOUR AU - Chen, N. G. AU - Szalay, A. A. PY - 2010 DA - 2010// TI - Oncolytic vaccinia virus: a theranostic agent for cancer JO - Future Virol VL - 5 UR - https://doi.org/10.2217/fvl.10.58 DO - 10.2217/fvl.10.58 ID - Chen2010 ER - TY - JOUR AU - Walsh, S. R. AU - Dolin, R. PY - 2011 DA - 2011// TI - Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors JO - Expert Rev Vaccines VL - 10 UR - https://doi.org/10.1586/erv.11.79 DO - 10.1586/erv.11.79 ID - Walsh2011 ER - TY - JOUR AU - Mell, L. K. AU - Brumund, K. T. AU - Daniels, G. A. AU - Advani, S. J. AU - Zakeri, K. AU - Wright, M. E. PY - 2017 DA - 2017// TI - Phase I trial of intravenous oncolytic vaccinia virus (Gl-Onc1) with cisplatin and radiotherapy in patients with locoregionally advanced head and neck carcinoma JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-3232 DO - 10.1158/1078-0432.CCR-16-3232 ID - Mell2017 ER - TY - JOUR AU - Lauer, U. M. AU - Schell, M. AU - Beil, J. AU - Berchtold, S. AU - Koppenhofer, U. AU - Glatzle, J. PY - 2018 DA - 2018// TI - Phase I study of oncolytic vaccinia virus GL-ONC1 in patients with peritoneal carcinomatosis JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-18-0244 DO - 10.1158/1078-0432.CCR-18-0244 ID - Lauer2018 ER - TY - JOUR AU - Nalca, A. AU - Zumbrun, E. E. PY - 2010 DA - 2010// TI - ACAM2000™: the new smallpox vaccine for United States Strategic National Stockpile JO - Drug Des Devel Ther VL - 4 UR - https://doi.org/10.2147/DDDT.S3687 DO - 10.2147/DDDT.S3687 ID - Nalca2010 ER - TY - JOUR AU - Monath, T. P. AU - Caldwell, J. R. AU - Mundt, W. AU - Fusco, J. AU - Johnson, C. S. AU - Buller, M. PY - 2004 DA - 2004// TI - ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)—a second-generation smallpox vaccine for biological defense JO - Int J Infect Dis VL - 8 UR - https://doi.org/10.1016/j.ijid.2004.09.002 DO - 10.1016/j.ijid.2004.09.002 ID - Monath2004 ER - TY - JOUR AU - Weltzin, R. AU - Liu, J. AU - Pugachev, K. V. AU - Myers, G. A. AU - Coughlin, B. AU - Blum, P. S. PY - 2003 DA - 2003// TI - Clonal vaccinia virus grown in cell culture as a new smallpox vaccine JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm916 DO - 10.1038/nm916 ID - Weltzin2003 ER - TY - JOUR AU - Osborne, J. D. AU - Silva, M. AU - Frace, A. M. AU - Sammons, S. A. AU - Olsen-Rasmussen, M. AU - Upton, C. PY - 2007 DA - 2007// TI - Genomic differences of vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3 JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.10.040 DO - 10.1016/j.vaccine.2007.10.040 ID - Osborne2007 ER - TY - JOUR AU - Downs-Canner, S. AU - Guo, Z. S. AU - Ravindranathan, R. AU - Breitbach, C. J. AU - O’Malley, M. E. AU - Jones, H. L. PY - 2016 DA - 2016// TI - Phase 1 study of intravenous oncolytic poxvirus (vvDD) in patients with advanced solid cancers JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.101 DO - 10.1038/mt.2016.101 ID - Downs-Canner2016 ER - TY - JOUR AU - Jefferson, A. AU - Cadet, V. E. AU - Hielscher, A. PY - 2015 DA - 2015// TI - The mechanisms of genetically modified vaccinia viruses for the treatment of cancer JO - Crit Rev Oncol Hematol VL - 95 UR - https://doi.org/10.1016/j.critrevonc.2015.04.001 DO - 10.1016/j.critrevonc.2015.04.001 ID - Jefferson2015 ER - TY - JOUR AU - Buller, R. M. AU - Smith, G. L. AU - Cremer, K. AU - Notkins, A. L. AU - Moss, B. PY - 1985 DA - 1985// TI - Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype JO - Nature VL - 317 UR - https://doi.org/10.1038/317813a0 DO - 10.1038/317813a0 ID - Buller1985 ER - TY - JOUR AU - Critchley-Thorne, R. J. AU - Simons, D. L. AU - Yan, N. AU - Miyahira, A. K. AU - Dirbas, F. M. AU - Johnson, D. L. PY - 2009 DA - 2009// TI - Impaired interferon signaling is a common immune defect in human cancer JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0901329106 DO - 10.1073/pnas.0901329106 ID - Critchley-Thorne2009 ER - TY - JOUR AU - Evgin, L. AU - Acuna, S. A. AU - Tanese de Souza, C. AU - Marguerie, M. AU - Lemay, C. G. AU - Ilkow, C. S. PY - 2015 DA - 2015// TI - Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques JO - Mol Ther VL - 23 UR - https://doi.org/10.1038/mt.2015.49 DO - 10.1038/mt.2015.49 ID - Evgin2015 ER - TY - JOUR AU - Lazennec, G. AU - Lam, P. Y. PY - 2016 DA - 2016// TI - Recent discoveries concerning the tumor—mesenchymal stem cell interactions JO - Biochim Biophys Acta VL - 1866 ID - Lazennec2016 ER - TY - JOUR AU - Berman, M. AU - Lander, E. PY - 2017 DA - 2017// TI - A prospective safety study of autologous adipose-derived stromal vascular fraction using a specialized surgical processing system JO - Am J Cosmetic Surg VL - 3 UR - https://doi.org/10.1177/0748806817691152 DO - 10.1177/0748806817691152 ID - Berman2017 ER - TY - JOUR AU - Souza, T. r. i. n. d. a. d. e. G. AU - Li, Y. AU - Olson, V. A. AU - Emerson, G. AU - Regnery, R. L. AU - Fonseca, F. G. PY - 2008 DA - 2008// TI - Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil JO - J Virol Methods VL - 152 ID - Souza2008 ER - TY - JOUR AU - McCart, J. A. AU - Ward, J. M. AU - Lee, J. AU - Hu, Y. AU - Alexander, H. R. AU - Libutti, S. K. PY - 2001 DA - 2001// TI - Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes JO - Can Res VL - 61 ID - McCart2001 ER - TY - JOUR AU - Park, B. H. AU - Hwang, T. AU - Liu, T. C. AU - Sze, D. Y. AU - Kim, J. S. AU - Kwon, H. C. PY - 2008 DA - 2008// TI - Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70107-4 DO - 10.1016/S1470-2045(08)70107-4 ID - Park2008 ER - TY - JOUR AU - Hopkins, R. J. AU - Lane, J. M. PY - 2004 DA - 2004// TI - Clinical efficacy of intramuscular vaccinia immune globulin: a literature review JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/422999 DO - 10.1086/422999 ID - Hopkins2004 ER - TY - JOUR AU - Minev, B. AU - Kohrt, H. AU - Kilinc, M. AU - Chen, N. AU - Feng, A. AU - Pessian, M. PY - 2014 DA - 2014// TI - Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation JO - J Immunother Cancer VL - 2 UR - https://doi.org/10.1186/2051-1426-2-S3-P112 DO - 10.1186/2051-1426-2-S3-P112 ID - Minev2014 ER - TY - JOUR AU - Zamarin, D. AU - Holmgaard, R. B. AU - Subudhi, S. K. AU - Park, J. S. AU - Mansour, M. AU - Palese, P. PY - 2014 DA - 2014// TI - Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3008095 DO - 10.1126/scitranslmed.3008095 ID - Zamarin2014 ER - TY - JOUR AU - Ribas, A. AU - Dummer, R. AU - Puzanov, I. AU - VanderWalde, A. AU - Andtbacka, R. H. I. AU - Michielin, O. PY - 2017 DA - 2017// TI - Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.08.027 DO - 10.1016/j.cell.2017.08.027 ID - Ribas2017 ER -